LFCR vs XOM · rev $75.5M vs P/E 24, rev $201.16B
Lifecore Biomedical Inc. (LFCR) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE. It is led by Darren Woods.
Latest reported LFCR revenue for 2025-12-31 was $75.5M. Net income was -$18.0M. Revenue was up 771.6% from 2025-06-30 to 2025-12-31. LFCR currently screens at market cap $207.1M.
Latest reported XOM revenue for 2026-06-30 was $201.16B. Net income was $18.71B. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
LFCR currently screens at market cap $207.1M. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the LFCR and XOM stock pages for the full models.
Not investment advice.